Source: ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Yuji Yamamoto, Kazuyuki Tsujino, Tomoki Kuge, Fukuko Okabe, Takahiro Kawasaki, Takanori Matsuki, Hiroyuki Kagawa, Mari Miki, Keisuke Miki, Masahide Mori, Hiroshi Kida. Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact. ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020

Member's Comments

No comment yet.

Related content which might interest you: Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016 Year: 2017 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Treatment outcome and prognostic factor in patients with mycobacterium avium complex pulmonary disease Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 A case of familial pulmonary Mycobacterium avium complex disease – experience in Japan Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Long-term survival of patients with mycobacterium avium- intracellulare complex pulmonary disease (MAC-PD) Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Pulmonary aspergilloma complicated by a cavitary lesion caused by pulmonary Mycobacterium avium complex disease Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005 Clinical study of mycobacterium avium complex pulmonary disease complicated by interstitial pneumonia Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections Year: 2011 Clinical features of radiologically atypical Mycobacterium kansasii lung disease in Japan Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018 Year: 2019 Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Combined chemotherapy in Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 657s Year: 2005 Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018 Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019